Clincosm LogoSign in Get a demo

Healthy Subjects

Showing NaN - NaN of 25
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Subjects Trial in Berlin (ACT-709478, Placebo, Midazolam)

Completed
  • Healthy Subjects
  • Berlin, Germany
    Parexel
Dec 20, 2019

Healthy Subjects Trial in Berlin (Moxifloxacin, Placebo, Lanifibranor)

Completed
  • Healthy Subjects
  • Berlin, Germany
    Parexel International GmbH
Oct 31, 2019

Safety, Tolerability, Pharmacokinetics Trial in Berlin (AZD9567 Monohydrat, Placebo oral suspension/ Placebo capsule,

Completed
Has Results
  • Safety
  • +5 more
  • AZD9567 Monohydrat
  • +2 more
  • Berlin, Germany
    Research Site
Sep 27, 2018

Healthy Subjects Trial in Berlin (AC-083, Placebo)

Completed
  • Healthy Subjects
  • Berlin, Germany
    Investigator Site
Jul 6, 2018

Healthy Subjects Trial in Berlin (AC-082, Placebo)

Completed
  • Healthy Subjects
  • Berlin, Germany
    Investigator Site
Jul 6, 2018

Molecular Reclassification to Find Clinically Useful Biomarkers

Completed
  • Healthy Subjects
    • Vienna, Austria
    • +16 more
    May 22, 2018

    Healthy Subjects Trial in Berlin (Mindfulness Walking)

    Completed
    • Healthy Subjects
    • Mindfulness Walking
    • Berlin, Germany
      Charité University Berlin
    Feb 20, 2018

    Bioavailability, Healthy Subjects Trial in Berlin (Naloxegol 25 mg tablet, crushed, suspended in water, given orally, Naloxegol

    Completed
    Has Results
    • Bioavailability
    • Healthy Subjects
    • Naloxegol 25 mg tablet, crushed, suspended in water, given orally
    • +3 more
    • Berlin, Germany
      Research Site
    Jan 30, 2017

    Healthy Subjects Trial in Leipzig, Berlin (Presence - Perspective - Affect, Presence - Affect - Perspective., Affect)

    Completed
    • Healthy Subjects
    • Presence - Perspective - Affect
    • +2 more
    • Leipzig, Sachsen, Germany
    • +1 more
    Dec 13, 2016

    Bioavailability, Healthy Subjects Trial in Berlin (Ticagrelor OD tablet (90 mg single dose) administered with 200 ml of water,

    Completed
    Has Results
    • Bioavailability
    • Healthy Subjects
    • Ticagrelor OD tablet (90 mg single dose) administered with 200 ml of water
    • +3 more
    • Berlin, Germany
      Research Site
    Aug 16, 2016

    Healthy Subjects Trial in Berlin (brain stimulation, SHAM)

    Completed
    • Healthy Subjects
    • brain stimulation
    • SHAM
    • Berlin, Germany
      Charite CCM Neurologie Berlin
    Mar 15, 2016

    Healthy Subjects Trial in Berlin (brain stimulation, no stimulation)

    Completed
    • Healthy Subjects
    • brain stimulation
    • no stimulation
    • Berlin, Germany
      Charite CCM Neurologie Berlin
    Mar 15, 2016

    Drug-Drug Interaction (DDI), Healthy Subjects, Pharmacokinetics of Enzalutamide Trial in Berlin (enzalutamide, rifampin)

    Completed
    • Drug-Drug Interaction (DDI)
    • +2 more
    • Berlin, Germany
      Parexel International GmbH
    Oct 14, 2014

    Pharmacokinetics of FG-4592, Healthy Subjects Trial in Berlin (Warfarin, FG-4592)

    Completed
    • Pharmacokinetics of FG-4592
    • Healthy Subjects
    • Berlin, Germany
      Parexel International GmbH
    Sep 26, 2014

    Healthy Subjects, Pharmacokinetics, Drug-Drug Interaction (DDI) Trial in Berlin (Mirabegron, Solifenacin succinate, Tamsulosin

    Completed
    • Healthy Subjects
    • +2 more
    • Berlin, Germany
      Parexel International GmbH
    Aug 27, 2014

    Healthy Subjects, Pharmacokinetics, Drug-Drug Interaction (DDI) Trial in Berlin (Mirabegron, Solifenacin, Digoxin)

    Completed
    • Healthy Subjects
    • +2 more
    • Berlin, Germany
      Parexel International GmbH
    Jul 9, 2014

    Pharmacokinetics, DDI (Drug-Drug Interaction), Healthy Subjects Trial in Berlin (ASP1707, itraconazole)

    Completed
    • Pharmacokinetics
    • +2 more
    • Berlin, Germany
      PAREXEL International GmbH
    Jul 1, 2014

    PK for FG-4592, Healthy Subjects Trial in Berlin (FG-4592, Placebo)

    Completed
    • PK for FG-4592
    • Healthy Subjects
    • Berlin, Germany
      Parexel International GmbH
    Jun 10, 2014

    Drug-Drug Interaction (DDI), Intestinal Absorption, Healthy Subjects Trial in Berlin (rosuvastatin, fidaxomicin)

    Completed
    • Drug-Drug Interaction (DDI)
    • +4 more
    • Berlin, Germany
      Parexel GmbH
    May 19, 2014

    Phase 1, Bioavailability, Healthy Subjects Trial in Berlin (solifenacin succinate, mirabegron, mirabegron/solifenacin succinate)

    Completed
    • Phase 1
    • +2 more
    • solifenacin succinate
    • +2 more
    • Berlin, Germany
      Parexel
    Dec 10, 2013

    Healthy Subjects, Castration Resistant Prostate Cancer (CRPC), Relative Bioavailability Trial in Berlin (MDV3100)

    Completed
    • Healthy Subjects
    • +3 more
    • Berlin, Germany
      Parexel International GmbH
    Jul 26, 2013

    Healthy Subjects Trial in Berlin (Litramine, Placebo)

    Completed
    • Healthy Subjects
    • Litramine
    • Placebo
    • Berlin, Germany
      Weißenseer Weg 111
    Jul 25, 2012

    Healthy Subjects Trial in Berlin (Homeopathic drug C12, Placebo)

    Completed
    • Healthy Subjects
    • Homeopathic drug C12
    • Placebo
    • Berlin, Germany
      Charité University
    Jul 9, 2012

    Healthy Subjects Trial in Berlin (Neramexane)

    Completed
    • Healthy Subjects
    • Berlin, Germany
      Parexel International GmbH
    Feb 14, 2011

    Healthy Subjects, Obesity, Diabetes, Type 1 Trial in Berlin (Glucagon HCl (GlucaGen®), NaCl 0.9%)

    Unknown status
    • Healthy Subjects
    • +2 more
    • Glucagon hydrochloride (GlucaGen®)
    • NaCl 0.9%
    • Berlin, Germany
      Charite Campus Benjamin Franklin
    Jun 29, 2009